Skip to search formSkip to main contentSkip to account menu

0.05 ML aflibercept 40 MG/ML Injection [Eylea]

Known as: aflibercept 40 mg in 1 mL INTRAVITREAL INJECTION, SOLUTION [EYLEA], Eylea 2 MG per 0.05 ML Intravitreal Injection, EYLEA 2 MG in 0.05 ML Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Purpose To assess the safety of biosimilar intravitreal aflibercept (CinnaGen Co., Iran) compared to the reference product (Eylea… 
2016
2016
Background: We sought to verify the efficacy and safety of transconjunctival 23-gauge pars plana vitrectomy (PPV) alone by our… 
2014
2014
  • myeye
  • 2014
  • Corpus ID: 238339929
EΓΧEΙΡΗΣΗ ΚΑΤΑΡΡΑΚΤΗ αντι VEGF παράγοντeς. Διάγνωση και EΓΧEΙΡΗΣΗ ΚΑΤΑΡΡΑΚΤΗ και αντι VEGF παράγοντeς .